Picture of Myriad Genetics logo

MYGN Myriad Genetics Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Annual balance sheet for Myriad Genetics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
June 30th
2020
June 30th
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments137218340115141
Net Total Accounts Receivable
Net Total Receivables1397191.3102114
Total Inventory
Prepaid Expenses
Total Current Assets349332485275314
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment57.3103125187181
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets1,5631,4051,3211,1991,147
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities118147204137156
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities474486353313363
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity1,089918968886783
Total Liabilities & Shareholders' Equity1,5631,4051,3211,1991,147
Total Common Shares Outstanding